Published in J Gen Virol on December 01, 2007
Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol (2010) 3.53
Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses. J Virol (2009) 1.19
PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J Gen Virol (2009) 1.18
Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J Virol (2010) 1.10
Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology (2009) 1.08
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice. PLoS One (2010) 0.97
Neuropeptide Y has a protective role during murine retrovirus-induced neurological disease. J Virol (2010) 0.94
Antiviral type I and type III interferon responses in the central nervous system. Viruses (2013) 0.88
MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma. J Virol (2015) 0.87
The transient nature of Bunyamwera orthobunyavirus NSs protein expression: effects of increased stability of NSs protein on virus replication. PLoS One (2013) 0.86
Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models. Mol Ther (2012) 0.86
Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection. J Neurovirol (2011) 0.85
Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice. J Virol (2012) 0.83
Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo. BMC Genomics (2009) 0.82
Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein. J Virol (2015) 0.81
Encapsidation of host-derived factors correlates with enhanced infectivity of Sindbis virus. J Virol (2013) 0.81
IFN-gamma-mediated suppression of coronavirus replication in glial-committed progenitor cells. Virology (2008) 0.81
An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology (2012) 0.80
Coinfection of tick cell lines has variable effects on replication of intracellular bacterial and viral pathogens. Ticks Tick Borne Dis (2014) 0.79
Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles. BMC Vet Res (2015) 0.76
Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity. Mol Ther Oncolytics (2017) 0.75
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol (2004) 3.52
Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol (2002) 2.50
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Phenoloxidase activity acts as a mosquito innate immune response against infection with Semliki Forest virus. PLoS Pathog (2012) 1.69
Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells. J Virol (2012) 1.58
Properly folded nonstructural polyprotein directs the semliki forest virus replication complex to the endosomal compartment. J Virol (2003) 1.52
Polypurine (A)-rich sequences promote cross-kingdom conservation of internal ribosome entry. Proc Natl Acad Sci U S A (2002) 1.45
Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog (2013) 1.42
Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog (2010) 1.39
Advances in dissecting mosquito innate immune responses to arbovirus infection. J Gen Virol (2009) 1.39
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One (2011) 1.37
Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J Virol (2006) 1.36
Regulation of the sequential processing of Semliki Forest virus replicase polyprotein. J Biol Chem (2003) 1.34
Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis. J Virol (2007) 1.33
Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J Virol (2003) 1.28
A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J Immunol (2012) 1.27
Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis. J Virol (2006) 1.26
A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus. J Virol (2002) 1.23
In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J Neuroimmunol (2005) 1.23
Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection. Mol Biol Cell (2012) 1.22
Gene expression profiling of the preclinical scrapie-infected hippocampus. Biochem Biophys Res Commun (2005) 1.21
Role of the amphipathic peptide of Semliki forest virus replicase protein nsP1 in membrane association and virus replication. J Virol (2006) 1.20
Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc Natl Acad Sci U S A (2010) 1.20
Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol (2013) 1.19
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial. Vaccine (2011) 1.18
PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J Gen Virol (2009) 1.18
Knockdown of piRNA pathway proteins results in enhanced Semliki Forest virus production in mosquito cells. J Gen Virol (2013) 1.17
Viperin restricts chikungunya virus replication and pathology. J Clin Invest (2012) 1.16
Attenuation of bunyavirus replication by rearrangement of viral coding and noncoding sequences. J Virol (2005) 1.16
Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res (2005) 1.14
T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. J Infect Dis (2012) 1.14
RNA interference targets arbovirus replication in Culicoides cells. J Virol (2012) 1.13
Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J Gen Virol (2007) 1.09
Homotypic interaction of Bunyamwera virus nucleocapsid protein. J Virol (2005) 1.09
Molecular determinants of substrate specificity for Semliki Forest virus nonstructural protease. J Virol (2006) 1.07
Modulation of Aire regulates the expression of tissue-restricted antigens. Mol Immunol (2007) 1.07
Semliki forest virus-induced endoplasmic reticulum stress accelerates apoptotic death of mammalian cells. J Virol (2010) 1.07
Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus. J Gen Virol (2008) 1.05
Novel functions of the alphavirus nonstructural protein nsP3 C-terminal region. J Virol (2009) 1.05
Cell-to-cell spread of the RNA interference response suppresses Semliki Forest virus (SFV) infection of mosquito cell cultures and cannot be antagonized by SFV. J Virol (2009) 1.04
Detection and identification of putative bacterial endosymbionts and endogenous viruses in tick cell lines. Ticks Tick Borne Dis (2012) 1.03
Understanding the Wolbachia-mediated inhibition of arboviruses in mosquitoes: progress and challenges. J Gen Virol (2013) 1.03
Central nervous system remyelination in culture--a tool for multiple sclerosis research. Exp Neurol (2011) 1.00
Therapeutics and vaccines against chikungunya virus. Vector Borne Zoonotic Dis (2015) 1.00
Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem Biophys Res Commun (2005) 1.00
Mutations at the palmitoylation site of non-structural protein nsP1 of Semliki Forest virus attenuate virus replication and cause accumulation of compensatory mutations. J Gen Virol (2007) 0.98
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog (2013) 0.98
Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J Gen Virol (2003) 0.97
Macromolecular assembly-driven processing of the 2/3 cleavage site in the alphavirus replicase polyprotein. J Virol (2011) 0.97
The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation. EMBO J (2004) 0.96
Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014. Emerg Infect Dis (2015) 0.96
Lyssavirus infection activates interferon gene expression in the brain. J Gen Virol (2006) 0.94
Innate immune response gene expression profiles of N9 microglia are pathogen-type specific. J Neuroimmunol (2006) 0.94
Tick cell lines for study of Crimean-Congo hemorrhagic fever virus and other arboviruses. Vector Borne Zoonotic Dis (2011) 0.92
Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with an inserted intron. J Virol Methods (2007) 0.92
Properties of non-structural protein 1 of Semliki Forest virus and its interference with virus replication. J Gen Virol (2008) 0.91
Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity. J Biol Chem (2014) 0.90
Magnetic fractionation and proteomic dissection of cellular organelles occupied by the late replication complexes of Semliki Forest virus. J Virol (2013) 0.89
RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog (2013) 0.88
Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice. J Gen Virol (2006) 0.87
Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses (2013) 0.85
In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination. J Gen Virol (2008) 0.85
Neurons and oligodendrocytes in the mouse brain differ in their ability to replicate Semliki Forest virus. J Neurovirol (2008) 0.84
Molecular defects caused by temperature-sensitive mutations in Semliki Forest virus nsP1. J Virol (2008) 0.84
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol J (2013) 0.84
Identification of mutations causing temperature-sensitive defects in Semliki Forest virus RNA synthesis. J Virol (2006) 0.84
Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis. J Virol (2013) 0.82
Properties and use of novel replication-competent vectors based on Semliki Forest virus. Virol J (2009) 0.82
viRome: an R package for the visualization and analysis of viral small RNA sequence datasets. Bioinformatics (2013) 0.82
Gene silencing in tick cell lines using small interfering or long double-stranded RNA. Exp Appl Acarol (2012) 0.82